Gilead Sciences Inc (GILD)
89.80
+1.17
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
89.80
0.00 (0.00%)
After-Hours: 17:30
Gilead Sciences Total Liabilities (Quarterly): 36.14B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 36.14B |
| June 30, 2024 | 35.38B |
| March 31, 2024 | 38.84B |
| December 31, 2023 | 39.38B |
| September 30, 2023 | 40.13B |
| June 30, 2023 | 41.24B |
| March 31, 2023 | 40.94B |
| December 31, 2022 | 41.96B |
| September 30, 2022 | 41.50B |
| June 30, 2022 | 42.66B |
| March 31, 2022 | 43.16B |
| December 31, 2021 | 46.89B |
| September 30, 2021 | 45.63B |
| June 30, 2021 | 48.27B |
| March 31, 2021 | 48.53B |
| December 31, 2020 | 50.19B |
| September 30, 2020 | 43.41B |
| June 30, 2020 | 37.79B |
| March 31, 2020 | 37.56B |
| December 31, 2019 | 38.98B |
| September 30, 2019 | 38.41B |
| June 30, 2019 | 40.46B |
| March 31, 2019 | 40.75B |
| December 31, 2018 | 42.14B |
| September 30, 2018 | 41.30B |
| Date | Value |
|---|---|
| June 30, 2018 | 43.62B |
| March 31, 2018 | 44.73B |
| December 31, 2017 | 49.78B |
| September 30, 2017 | 39.41B |
| June 30, 2017 | 37.17B |
| March 31, 2017 | 36.78B |
| December 31, 2016 | 37.61B |
| September 30, 2016 | 39.25B |
| June 30, 2016 | 33.86B |
| March 31, 2016 | 33.75B |
| December 31, 2015 | 32.60B |
| September 30, 2015 | 32.69B |
| June 30, 2015 | 22.53B |
| March 31, 2015 | 20.73B |
| December 31, 2014 | 18.84B |
| September 30, 2014 | 14.98B |
| June 30, 2014 | 14.78B |
| March 31, 2014 | 14.38B |
| December 31, 2013 | 10.83B |
| September 30, 2013 | 11.28B |
| June 30, 2013 | 11.28B |
| March 31, 2013 | 11.82B |
| December 31, 2012 | 11.70B |
| September 30, 2012 | 12.21B |
| June 30, 2012 | 12.42B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
35.38B
Minimum
Jun 2024
50.19B
Maximum
Dec 2020
41.93B
Average
41.37B
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Merck & Co Inc | 72.97B |
| Pfizer Inc | 126.92B |
| Vertex Pharmaceuticals Inc | 6.609B |
| Amgen Inc | 83.36B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.52B |
| Shareholders Equity (Quarterly) | 18.47B |
| Debt to Equity Ratio | 1.258 |
| Current Ratio | 1.261 |
| Net Debt Paydown Yield | 0.38% |